AMT (Alpha-Methyltryptamine) – Scientific Product Description

General Information

Substance Name:  Alfa-metüültrüptamiin (AMT)
Keemiline klass:  Trüptamiini derivaat
Staatus:  Research chemical
Annustamine:  Varies (10-50mg for research purposes)
Vorm:  Powder or pellets (depending on availability)

Farmakoloogilised omadused

AMT is a monoamine alkaloid with a unique mechanism of action that both:

• Serotonergic  (5-HT₂A agonism)

• Dopaminergic  (dopamine reuptake inhibition)

• Exhibits noradrenergic  effects

Potentsiaalsed uurimisvaldkonnad

1. Neuropsychological Examination

• Influence on perceptual processing

• Modulation of cognitive flexibility

• Effects on creative thinking

2. Behavioral Science Studies

• Social interaction patterns

• Emotional processing mechanisms

• Motivation and reward systems

3. Theoretical Applications

• Possible antidepressant effects (preclinical study)

• Impact on sleep architecture

• Neuroplastic changes

Dosage & Protocol

Research dose range:

• Madal annus:  10–20 mg

• Keskmine annus:  20–35 mg

• Suur annus:  35–50 mg

Time lapse:

• Onset of effects: 45-90 minutes

• Peak performance: 3-5 hours

• Total duration: 8-12 hours

Safety aspects

Kõrvaltoimed

• Increased body temperature

• Tachycardia

• Müdriaasi

• Possible gastrointestinal discomfort

Contraindications

• Combination with MAO inhibitors

• Cardiovascular diseases

• Psychiatric history

Laboratoorsed analüüsid

Puhtus:  ≥97% (HPLC)
Stabiilsus:  Hoida jahedas ja kuivas kohas (<25°C)
Impurities:  <0.5% (GC-MS analysis)

Õiguslik staatus

Holland:  Opium Act Schedule I
Belgium:  Prohibited substance
EL:  Under EU NPS legislation

Research protocols

1. Start low:  10mg initial test dose

2. Pharmaceutical monitoring:  Blood pressure and temperature measurement

3. Intervals:  Minimum 7 days between experiments

Olulised hoiatused

❌ Ei ole inimtoiduks
❌ Do not combine with other psychoactives
❌ Avoid prolonged or frequent use

This product is intended solely for in vitro research ja scientific study under controlled laboratory conditions.

1cP-LSD 150 MCG kunstipaberit O-DSMT 50 mg graanulid 1V-LSD 150 MCG blotterid 6-CL-ADBA